BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25134778)

  • 1. Risk factors for pregnancy outcomes in patients with IgA nephropathy: a matched cohort study.
    Liu Y; Ma X; Lv J; Shi S; Liu L; Chen Y; Zhang H
    Am J Kidney Dis; 2014 Nov; 64(5):730-6. PubMed ID: 25134778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
    Sarcina C; Tinelli C; Ferrario F; Pani A; De Silvestri A; Scaini P; Del Vecchio L; Alberghini E; Buzzi L; Baragetti I; Pozzi C
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):973-981. PubMed ID: 27129712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Phosphorus Might Be a Predictor of Kidney Disease Progression in IgA Nephropathy.
    Li H; Lu W; Xie X; Wang Y; Dang X; Sun J; Jiang H
    Kidney Blood Press Res; 2024; 49(1):20-26. PubMed ID: 38048756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dividing CKD stage 3 into G3a and G3b could better predict the prognosis of IgA nephropathy.
    Zhang JJ; Yu GZ; Zheng ZH; Liu YF; Du YY; Quan SX; Liu YJ; Lv JC; Zhang H
    PLoS One; 2017; 12(4):e0175828. PubMed ID: 28414748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study.
    Wang CS; Glenn DA; Helmuth M; Smith AR; Bomback AS; Canetta PA; Coppock GM; Khalid M; Tuttle KR; Bou-Matar R; Greenbaum LA; Robinson BM; Holzman LB; Smoyer WE; Rheault MN; Gipson D; Mariani LH;
    Am J Kidney Dis; 2024 Jan; 83(1):37-46. PubMed ID: 37657635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of corticosteroids in Norwegian patients with immunoglobulin a nephropathy progressing to end-stage kidney disease: a retrospective cohort study.
    Rivedal M; Haaskjold YL; Eikrem Ø; Bjørneklett R; Marti HP; Knoop T
    BMC Nephrol; 2024 Jan; 25(1):42. PubMed ID: 38287343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study.
    Tang C; Chen P; Si FL; Lv JC; Shi SF; Zhou XJ; Liu LJ; Zhang H
    Am J Kidney Dis; 2024 Feb; ():. PubMed ID: 38364955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and Clinical Outcomes of Membranous Nephropathy, IgA Nephropathy, and Minimal Change Disease Two Years Post-Kidney Biopsy.
    Guo X; Tie X; Zhang Y; Dai Y; Yao S; Qiao X; Wang L; Su X
    Kidney Blood Press Res; 2024; 49(1):345-354. PubMed ID: 38615671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-Pregnancy eGFR and the Risk of Adverse Maternal and Fetal Outcomes: A Population-Based Study.
    Tangren J; Bathini L; Jeyakumar N; Dixon SN; Ray J; Wald R; Harel Z; Akbari A; Mathew A; Huang S; Garg AX; Hladunewich MA
    J Am Soc Nephrol; 2023 Apr; 34(4):656-667. PubMed ID: 36735377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of fibrinoid necrosis on the clinical features and outcomes of primary IgA nephropathy.
    Chen H; Liu Y; Wei L; Wang H; Zheng Z; Yan T; Jia J; Li D
    BMC Nephrol; 2023 Dec; 24(1):366. PubMed ID: 38082385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating soluble CD30 is associated with renal tertiary lymphoid structures and the progression of IgA nephropathy.
    Luo R; Qian D; Yang D; Cheng Y; Li J; Liu L; Li Y; Lei Q; Chang X; Liu Y; Xu G; Ge S
    Clin Chim Acta; 2024 Apr; 557():117888. PubMed ID: 38527714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes in IgA Nephropathy.
    Pitcher D; Braddon F; Hendry B; Mercer A; Osmaston K; Saleem MA; Steenkamp R; Wong K; Turner AN; Wang K; Gale DP; Barratt J
    Clin J Am Soc Nephrol; 2023 Jun; 18(6):727-738. PubMed ID: 37055195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis.
    Inker LA; Heerspink HJL; Tighiouart H; Chaudhari J; Miao S; Diva U; Mercer A; Appel GB; Donadio JV; Floege J; Li PKT; Maes BD; Locatelli F; Praga M; Schena FP; Levey AS; Greene T
    Am J Kidney Dis; 2021 Sep; 78(3):340-349.e1. PubMed ID: 33775708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive blood pressure control and the progression of IgA nephropathy: a cohort study using marginal structural models.
    Tang C; Chen P; Si FL; Yao YX; Lv JC; Shi SF; Zhou XJ; Liu LJ; Zhang H
    Nephrol Dial Transplant; 2023 Dec; 39(1):55-63. PubMed ID: 37391382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes for kidney transplantation in 81 adults with IgA nephropathy.
    Tang Z; Li T; Feng C; Peng L; Xie X; Peng F; Lan G; Yu S; Wang Y; Dai H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1017-1025. PubMed ID: 37724404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reassuring pregnancy outcomes in women with mild COL4A3-5-related disease (Alport syndrome) and genetic type of disease can aid personalized counseling.
    Gosselink ME; Snoek R; Cerkauskaite-Kerpauskiene A; van Bakel SPJ; Vollenberg R; Groen H; Cerkauskiene R; Miglinas M; Attini R; Tory K; Claes KJ; van Calsteren K; Servais A; de Jong MFC; Gillion V; Vogt L; Mastrangelo A; Furlano M; Torra R; Bramham K; Wiles K; Ralston ER; Hall M; Liu L; Hladunewich MA; Lely AT; van Eerde AM;
    Kidney Int; 2024 May; 105(5):1088-1099. PubMed ID: 38382843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort Study.
    Canney M; Gunning HM; Johnston JC; Induruwage D; Zheng Y; Barbour SJ
    Am J Kidney Dis; 2023 Dec; 82(6):725-736. PubMed ID: 37516296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albuminuria predicts kidney events in IgA nephropathy.
    Faucon AL; Lundberg S; Lando S; Wijkström J; Segelmark M; Evans M; Carrero JJ
    Nephrol Dial Transplant; 2024 Apr; ():. PubMed ID: 38688876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of IgA nephropathy diagnosis in the Swedish Renal Registry.
    Rehnberg J; Segelmark M; Ludvigsson JF; Emilsson L
    BMC Nephrol; 2024 Mar; 25(1):78. PubMed ID: 38438966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of normal-range serum phosphorus with immunoglobulin A nephropathy progression: a retrospective cohort study.
    An X; Ding L; Yang Y; Yang Z; Zhang Y; Bai F; Liu L; Shi W; Yang X
    Int Urol Nephrol; 2024 Jan; 56(1):275-282. PubMed ID: 37336802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.